Randomized trial to Compare Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pai
Not Applicable
- Conditions
- Health Condition 1: C01- Malignant neoplasm of base of tongueHealth Condition 2: C10- Malignant neoplasm of oropharynxHealth Condition 3: C05- Malignant neoplasm of palateHealth Condition 4: C09- Malignant neoplasm of tonsil
- Registration Number
- CTRI/2019/08/020712
- Lead Sponsor
- Mukesh Yadav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a) Age > 18years
b) Patients with proven carcinoma of the oropharynx and supraglottic larynx with estimated survival of 3 months or more.
c) Pain lasting for at least 2 weeks with an average intensity of 5 or more on an 11-point numeric rating scale (NRS) refractory to a combination strong opioids and NSAIDS
Exclusion Criteria
5.3. Exclusion criteria
a) Local infection or skin ulceration at the puncture site
b) Local anaesthetic allergy
c) Psychiatric illness that affected cooperation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method